ASND   $153.755  3.36% Market Open

Ascendis Pharma A/S
Total Cash 258.70M
totalCashPerShare 4.511
EBITDA -347.19M
Total Debt 672.64M
quickRatio 0.4
currentRatio 0.74
Total Revenue 317.63M
debtToEquity
Revenue/Share 5.595
ROA -0.27923
ROE
grossProfits
freeCashflow -104.13M
operatingCashflow -330.08M
earningsGrowth
revenueGrowth -0.24
grossMargins 0.85556
ebitdaMargins -1.09308
operatingMargins -3.7017899
profitMargins -1.54116
enterpriseValue 7.25B
forwardPE -34.656975
floatShares 56.91M
sharesOutstanding 57.35M
sharesShort 3.52M
sharesShortPriorMonth 3.50M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.08%
Short Ratio help_outline 8.82%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue -5.6
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -489.52M
trailingEps -9.49%
forwardEps -3.44%
enterpriseToEbitda -20.89
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.37 3Q 2024
institutionsCount 287
lastUpdated Sept. 16, 2024, 12:45 p.m.